Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65 - researchr publication related

researchr

You are not signed in
Sign in
Sign up

Xi-Ping Huang, Joel Karpiak, Wesley K. Kroeze, Hu Zhu, Xin Chen, Sheryl S. Moy, Kara A. Saddoris, Viktoriya D. Nikolova, Martilias S. Farrell, Sheng Wang, Thomas J. Mangano, Deepak A. Deshpande, Alice Jiang, Raymond B. Penn, Jian Jin, Beverly H. Koller, Terry Kenakin, Brian K. Shoichet, Bryan L. Roth. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature, 527(7579):477-483, 2015. [doi]

The following publications are possibly variants of this publication:

Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamicsWen-Yan Jin, Ying Ma, Wei-Ya Li, Hong-Lian Li, Run-ling Wang. CANDC, 73:179-188, 2018. [doi]

Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic ReceptorYue Chen, Oliver Fleetwood, Sergio Pérez-Conesa, Lucie Delemotte. jcisd, 61(12):6024-6037, 2021. [doi]

runs on WebDSL